Article in Infection and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Kate R FortneyDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Julie A BrothwellDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA.ORCID 0000-0002-5277-3692
Teresa A BatteigerDepartment of Medicine, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Rory DuplantierDepartment of Medicine, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Barry P KatzDepartment of Biostatistics and Health Data Science, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Stanley M SpinolaDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, USA.ORCID 0000-0003-3435-9911
Funding
Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Very Late Antigen Integrin Activity on T CellsR01AI031126 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1996 to 2010
$3.7M
Determination of the Interactome between Haemophilus ducreyi and the Human Host.R01AI137116 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI SPINOLA, STANLEY M. · 2020 to 2024
$3.2M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI37116NCATS NIH HHS UL1 TR002529NIAID NIH HHS R01 AI031126NIAID NIH HHS R01 AI137116
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Bacterial ProteinsChancroidHaemophilus ducreyiIronAdultHemeHumansMaleVirulenceBacterial ProteinsHemeIronHaemophilus ducreyihuman infectioniron transport
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.